1. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018 Subject(s): Immunotherapy, AdoptiveLeukemia, B-Cell -- drug therapyLymphoma, B-Cell -- drug therapyLymphoma, Non-Hodgkin -- drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapyAdultChildClinical Trials as TopicClofarabine -- therapeutic useCost-Benefit AnalysisImmunotherapy, Adoptive -- adverse effectsImmunotherapy, Adoptive -- economicsReceptors, Chimeric Antigen -- therapeutic useTreatment OutcomeHumansUnited States